Michael A. Klobuchar
Chief Operating OfficerMr. Michael A. Klobuchar, also known as Mike, is Chief Operating Officer since November 2024 at Eikon Therapeutics, Inc. He has served as Director of Revvity, Inc. from February 1, 2024 and also serves as its Independent Director. He served as Executive Vice President and Chief Strategy Officer of Merck & Co. Inc. since July 5, 2021 until October 2024. In this role he leads the advancement and execution of Merck’s strategy, with additional responsibility for business development and information technology. He was Senior Vice President of Merck Research Laboratories Finance and Global Project and Alliance Management since January 2019 until July 5, 2021. Mr. Klobuchar was Senior Vice President, CFO and Head of Portfolio and Alliance Management for Merck Research Laboratories, the company’s research and development organization, from 2019 to 2021 and led the Global Portfolio and Alliance Management group within that organization. He was Merck's Senior Vice President of Corporate Strategy and Financial Planning and President of Emerging Businesses (December 2017-January 2019); Prior to that, Vice President, Global Business and Financial Planning, Merck Global Health Innovation Fund. He joined Merck in 1998 as a synthetic process development engineer supporting new pipeline candidates within MRL and has since held key technical, operational and financial roles across several areas in Merck. He has a Bachelor of Science degree in Chemical Engineering from Purdue University, a Master of Science degree in Chemical Engineering from Rutgers University and a Master of Business Administration degree from Villanova University.
Positions
- Company NameEikon Therapeutics, Inc.Stock CodeEIKNPositionChief Operating OfficerColleagues
- RMRoger M. PerlmutterChairman, President & CEO
- RDRoy D. BaynesExecutive VP & Chief Medical Officer
- RTRobert TjianCo-Founder & Member of Scientific Advisory Board
- EBEric BetzigCo-Founder & Member of Scientific Advisory Board
- KCKenneth C. FrazierIndependent Director
- RLRobert Luther HuffinesIndependent Director
